Comprehensive Biochemistry: Glucose Metabolism and Regulation

Primary Glucose Metabolic Pathways

• Glycolysis: The metabolic process involving the breakdown of glucose into pyruvate to yield energy.
• Gluconeogenesis: The synthesis of glucose by combining smaller carbon-containing compounds.
• Glycogen Synthesis and Breakdown: The processes of storing glucose as a glycogen polymer or recovering it from storage.

The Ten Steps of Glycolysis

Glycolysis is a 10-step pathway that converts one 6-carbon glucose molecule into two 3-carbon pyruvate molecules. This process is divided into two distinct phases.

The Energy Investment Phase (Steps 1–5)

• In this phase, $2$ ATP molecules are hydrolyzed to ADP for every one molecule of glucose.
• Step 1: Hexokinase Reaction
  • Kinases are enzymes that phosphorylate molecules.
  • ATP is invested, and the hydrolysis of ATP drives the reaction.
  • This reaction is irreversible.
  • The product, Glucose 6-phosphate ($G-6-P$), is an intermediate for several metabolic pathways and is not yet committed to glycolysis.
• Step 2: Phosphoglucose Isomerase Reaction
  • This step involves the conversion of an aldose (glucose) to a ketose (fructose).
  • It also involves a structural change from a pyranose ring to a furanose ring.
  • This reaction is near equilibrium and is reversible.
• Step 3: Phosphofructokinase-1 (PFK-1) Reaction
  • A second ATP molecule is invested, driven by ATP hydrolysis.
  • The reaction is irreversible.
  • This is the first committed step of glycolysis and is highly regulated.
• Step 4: Aldolase Reaction
  • This reaction is the reverse of an aldol condensation.
  • One 6-carbon glucose-derived molecule (Fructose 1,6-bisphosphate) is cleaved into two 3-carbon sugars.
• Step 5: Triose Phosphate Isomerase Reaction
  • This step is the reversible interconversion of dihydroxyacetone phosphate (DHAP) and glyceraldehyde 3-phosphate (GAP).
  • While the standard free energy change ($\Delta G$) is greater than $0$ for the conversion of DHAP to GAP, the reaction proceeds forward in the cell because GAP is rapidly consumed in Step 6.
  • At equilibrium, approximately $94\%$ of the molecules are DHAP and $6\%$ are GAP.
  • Triose phosphate isomerase is considered a "perfect" enzyme because its rate of catalysis is diffusion-limited.
  • The enzyme provides significant transition state stabilization through conformational changes upon binding.

The Energy Payoff Phase (Steps 6–10)

• In this phase, $4$ ATP molecules are generated per glucose, resulting in a net gain of $2$ ATP.
• $2$ $NAD^+$ electron carriers are reduced to $2$ $NADH$. These can be oxidized later in the Electron Transport Chain to generate more ATP.
• Step 6: GAP Dehydrogenase Reaction
  • This reaction is both a phosphorylation and an oxidation-reduction reaction.
  • The phosphate group utilized here does not come from ATP; it proceeds through a high-energy thioester intermediate.
  • $NAD^+$ is reduced to $NADH$.
  • This reaction is strongly inhibited by arsenate ($AsO_4^{3-}$), which competes with phosphate ($PO_4^{2-}$) for the enzyme binding site.
• Step 7: Phosphoglycerate Kinase Reaction
  • ATP is generated via substrate-level phosphorylation.
  • Because there are two molecules of 1,3-bisphosphoglycerate ($1,3-BPG$) per glucose, this reaction occurs twice, recouping the initial investment of $2$ ATP.
  • At this specific step, the net yield of ATP for the entire glycolytic pathway is zero.
• Step 8: Phosphoglycerate Mutase Reaction
  • The phosphate group is moved from the C-3 position to the C-2 position.
  • Relocating the phosphate closer to the carboxylic acid increases the energy of the phosphoester bond.
  • The isomerization is catalyzed by a phosphorylated histidine at the active site, while a lysine side chain stabilizes the carboxylic acid.
• Step 9: Enolase Reaction
  • Enolase catalyzes a dehydration reaction to create the "enol" form of the substrate.
  • The resulting phosphorylated enol is a high-energy species capable of transferring a phosphate to ADP.
• Step 10: Pyruvate Kinase Reaction
  • ATP is formed through a second substrate-level phosphorylation.
  • The initial product is the enol form of pyruvate, which then tautomerizes into pyruvate.
  • This results in a final net gain of $2$ ATP per glucose.

Energetics of Glycolysis

• Standard Gibbs free energy changes ($\Delta G^{\circ \prime}$) suggest several steps are disfavored (positive values).
• Under physiological conditions, cellular concentrations of metabolites ensure that $\Delta G \approx 0$ for many steps or is negative, making all reactions spontaneous.
• Irreversible Steps: Steps 1, 3, and 10 are the only irreversible reactions in the pathway.
• Step 5 is endergonic but is driven forward by the concentration gradient of GAP.

Gluconeogenesis

Gluconeogenesis is the formation of glucose from pyruvate (derived from glycolysis) or oxaloacetate (derived from the TCA cycle).

• While many glycolysis enzymes catalyze reversible reactions and are shared, four unique enzymes are required to bypass the irreversible steps of glycolysis:
  1. Pyruvate carboxylase
  2. Phosphoenolpyruvate carboxykinase
  3. Fructose bisphosphatase
  4. Glucose-6-phosphatase
• Pyruvate to PEP: This is an endergonic process occurring in two steps. It requires the hydrolysis of both $1$ ATP and $1$ GTP. $CO_2$ is added in the first step and released in the second.
• The final two unique enzymes of the pathway are phosphatases.
• Regulation: Glycolysis and gluconeogenesis are opposing pathways. If they occurred simultaneously, there would be a net consumption of ATP. They are regulated as a "switch" to meet cellular needs, notably at the fructose bisphosphatase step facilitated by Fructose-2,6-bisphosphate ($Fru-2,6-BP$).

Regulation of Metabolic Pathways

General Principles

• Product Inhibition: The final product of a pathway allosterically inhibits an earlier enzyme to prevent unnecessary accumulation and resource investment.
• Feed-Forward Activation: An early product (after the committed step) activates a later enzyme to manage a backlog of intermediates and increase the overall pathway rate.
• Covalent Modification: Post-translational modifications, such as phosphorylation by kinases or dephosphorylation by phosphatases, modulate protein activity. Other modifications include acetylation, methylation, and glycosylation.
• Synthesis and Degradation: Hormones can induce changes in the total amount of enzyme present in a cell. This signal is slower to take effect but is long-lasting.

Specific Regulation of Glycolysis

• Hexokinase: In most tissues, hexokinase (Isoforms I-III) is inhibited by its product, Glucose 6-phosphate. However, Liver Hexokinase IV (glucokinase) is not inhibited by $G-6-P$, allowing the liver to continue glucose uptake when levels are high. $G-6-P$ serves as a substrate for glycolysis, glycogen synthesis, and the pentose phosphate pathway.
• Phosphofructokinase-1 (PFK-1): This is the most highly regulated step. Allosteric regulation varies by species:
  • ATP: Inhibits in most species (rare example of substrate inhibition).
  • Citrate: Inhibits in most species.
  • ADP: Activates in bacteria.
  • AMP: Activates in mammals. Mammalian PFK-1 is highly sensitive to AMP because ATP levels remain relatively stable, while AMP levels fluctuate significantly with the cell's energy state.
  • PEP: Inhibits in bacteria.
  • Fructose-2,6-bisphosphate ($Fru-2,6-BP$): Potent activator in mammals.
• Pyruvate Kinase:
  • Feed-forward activation: Activated by Fructose 1,6-bisphosphate.
  • Product inhibition: Inhibited by ATP.
  • Covalent modification: Inactivated by Protein Kinase A (PKA) via phosphorylation.

Signaling and Second Messengers

Signal Transduction Mechanisms

• G-Protein Receptors: These are complexes consisting of a receptor and a multi-subunit G-protein ($\alpha$, $\beta$, and $\gamma$).
  • The $\alpha$ subunit is inactive when bound to GDP and active when bound to GTP.
  • Ligand binding triggers the release of GDP and the binding of GTP, causing the $\alpha$ subunit to dissociate and modulate other proteins.
  • The native GTPase activity of the $\alpha$ subunit eventually hydrolyzes GTP to GDP, leading to reassociation with the $\beta\gamma$ complex.
• Secondary Messengers: Activated G-proteins often modulate Adenylate Cyclase, which converts ATP into cyclic AMP (cAMP).
• Protein Kinase A (PKA): cAMP binds to the regulatory (R) domains of PKA, releasing active catalytic (C) subunits. These subunits phosphorylate regulatory proteins to amplify the signal. cAMP is eventually inactivated by phosphodiesterase which hydrolyzes it to AMP.

Hormonal Control of Glucose

• Glucagon: Indicates low blood glucose. It triggers cAMP production, activating PKA.
  • PKA phosphorylates the bifunctional enzyme PFK-2 / FBPase-2.
  • Phosphorylation inactivates PFK-2 and activates FBPase-2, leading to a drop in $Fru-2,6-BP$ levels.
  • Lower $Fru-2,6-BP$ decreases glycolysis and stimulates gluconeogenesis.
• Epinephrine (Fight or Flight): Leads to the activation of PKA, which activates glycogen phosphorylase to break down glycogen into glucose for immediate energy use.
• Insulin: Signals high blood sugar. It uses Tyrosine Kinase Receptors, which autophosphorylate upon ligand binding. This activates Protein Kinase B (PKB) and Protein Kinase C (PKC).
  • Insulin activates glycogen synthesis.
  • PKC stimulates the translocation of glucose transporters to the cell surface to increase glucose uptake.

Glycogen Metabolism

• Synthesis: Glycogen is assembled from Glucose 1-phosphate ($G-1-P$).
  • $G-6-P$ is converted to $G-1-P$ by phosphoglucomutase.
  • $G-1-P$ reacts with UTP to form UDP-glucose and pyrophosphate.
  • The exergonic hydrolysis of inorganic pyrophosphate drives the reaction.
  • Glycogen synthase adds UDP-glucose to the growing glycogen molecule.
• Glycogenolysis:
  • Linear chains are broken down via phosphorolysis.
  • Branched chains are broken down via hydrolysis.
  • Product $G-6-P$ can enter glycolysis at Step 2; this consumes one less ATP than glucose from the bloodstream, compensating for the UTP used during synthesis.

Entry of Other Sugars and Pyruvate Fates

Other Sugars

• Galactose: Reacts with UDP-glucose to form UDP-galactose, which is converted to UDP-glucose by UDP-glucose-4-epimerase. It enters as $G-6-P$.
• Mannose: Phosphorylated to mannose 6-phosphate, then converted to $F-6-P$ by phosphomannose isomerase.
• Fructose:
  • In muscle, small intestine, and kidneys: Converted to $F-6-P$ by hexokinase.
  • In the liver: Liver glucokinase cannot phosphorylate fructose at C6. Instead, it is phosphorylated at C1 to $F-1-P$, and then cleaved into DHAP and glyceraldehyde.

Pates of Pyruvate

1. Acetyl-CoA: Pyruvate is oxidized and decarboxylated (3C to 2C). Acetyl-CoA enters the TCA cycle or is used for fatty acid biosynthesis.
2. Oxaloacetate: A key metabolite for the TCA cycle, gluconeogenesis, and amino acid biosynthesis.
3. Lactate: In anaerobic conditions (e.g., muscle contraction), pyruvate is converted to lactate to regenerate $NAD^+$ for glycolysis.
   • Cori Cycle: Lactate from muscle travels to the liver to be converted back into glucose via gluconeogenesis.
4. Ethanol: In organisms like yeast, anaerobic fermentation converts pyruvate to ethanol to regenerate $NAD^+$.
   • Ethanol in humans is processed in the liver into acetate, generating two $NADH$ molecules.

The Pentose Phosphate Pathway (PPP)

This oxidative pathway produces NADPH and ribose (the sugar for RNA and DNA).

• Stages:
  1. Oxidative Stage: Sugar is oxidized and decarboxylated, yielding reduced NADPH.
  2. Non-oxidative Stage: Three ribulose-5-phosphate (5C) molecules interconvert to form two fructose-6-phosphate (6C) and one glyceraldehyde-3-phosphate (3C).
• NADPH vs. NADH:
  • The extra phosphate in NADPH allows enzymes to discriminate between the two.
  • NADPH: High concentration maintained ($NADPH/NADP^+$ is high). Used for anabolic biosynthesis and protecting the cell from oxidative stress.
  • NADH: Low concentration maintained ($NADH/NAD^+$ is low). Used mostly for catabolic energy production.
• Oxidative Stress Protection: NADPH is the cofactor for glutathione reductase, which reduces oxidized glutathione. Reduced glutathione is the primary antioxidant protecting cells from Reactive Oxygen Species (ROS).

Clinical Correlation: Glucose-6-Phosphate Dehydrogenase (G6PDH) Deficiency

• General: More than $400$ million people are affected by G6PDH deficiency, making it the most common human enzyme defect. It is X-chromosome linked.
• Symptoms: Hemolysis (breakdown of red blood cells).
• Pathophysiology: Red blood cells only carry one isoform of G6PDH and have a high risk of oxidation due to oxygen transport. Without G6PDH, they cannot generate enough NADPH to maintain reduced glutathione.
• Environmental Triggers: Hemolysis can be triggered by antimalarial drugs (primaquine, chloroquine), sulfonamides, aspirin, certain antibiotics (furazolidone), and henna.
• Evolutionary Advantage: G6PDH deficiency provides resistance against the malaria parasite.